BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37848688)

  • 21. Prognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Therapy.
    Chatterjee D; Katz MH; Foo WC; Sundar M; Wang H; Varadhachary GR; Wolff RA; Lee JE; Maitra A; Fleming JB; Rashid A; Wang H
    Am J Surg Pathol; 2017 Aug; 41(8):1097-1104. PubMed ID: 28614206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Changes in the American Joint Committee on Cancer Staging Manual, Eighth Edition, for Pancreatic Ductal Adenocarcinoma.
    Kassardjian A; Stanzione N; Donahue TR; Wainberg ZA; Damato L; Wang HL
    Pancreas; 2019 Aug; 48(7):876-882. PubMed ID: 31268985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma.
    Allen PJ; Kuk D; Castillo CF; Basturk O; Wolfgang CL; Cameron JL; Lillemoe KD; Ferrone CR; Morales-Oyarvide V; He J; Weiss MJ; Hruban RH; Gönen M; Klimstra DS; Mino-Kenudson M
    Ann Surg; 2017 Jan; 265(1):185-191. PubMed ID: 27163957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A proposal to modify the 8th edition of the UICC staging system for pancreatic adenocarcinoma.
    Matsumoto T; Okabayashi T; Sui K; Kimura J; Morita S; Iwata J; Iiyama T; Kubota K; Shimada Y
    Langenbecks Arch Surg; 2021 May; 406(3):667-677. PubMed ID: 33855599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival effect of tumor size and extrapancreatic extension in surgically resected pancreatic cancer: proposal for improved T classification.
    Park H; An S; Eo SH; Song KB; Park JH; Kim KP; Lee SS; Cho H; Seo DW; Kim SC; Yu E; Hong SM
    Hum Pathol; 2014 Nov; 45(11):2341-6. PubMed ID: 25248573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation.
    Estrella JS; Rashid A; Fleming JB; Katz MH; Lee JE; Wolf RA; Varadhachary GR; Pisters PW; Abdalla EK; Vauthey JN; Wang H; Gomez HF; Evans DB; Abbruzzese JL; Wang H
    Cancer; 2012 Jan; 118(1):268-77. PubMed ID: 21735446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma.
    Shin DW; Lee JC; Kim J; Woo SM; Lee WJ; Han SS; Park SJ; Choi KS; Cha HS; Yoon YS; Han HS; Hong EK; Hwang JH
    Eur J Surg Oncol; 2019 Nov; 45(11):2159-2165. PubMed ID: 31202572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Refined prognostic staging for resected pancreatic cancer by modified stage grouping and addition of tumour grade.
    König AK; Gros H; Hinz U; Hank T; Kaiser J; Hackert T; Bergmann F; Büchler MW; Strobel O
    Eur J Surg Oncol; 2022 Jan; 48(1):113-120. PubMed ID: 34344573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of the eighth edition of the American Joint Committee on Cancer staging system and proposal of an improved staging system for pancreatic ductal adenocarcinoma.
    Park MY; Shin SH; Song KB; Hwang D; Lee JH; Lee YJ; Kim SC
    Ann Hepatobiliary Pancreat Surg; 2019 Feb; 23(1):46-55. PubMed ID: 30863807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the New T1 Category as Defined in the Eighth Edition of the AJCC Pancreatic Cancer Staging System an Improvement?
    Kwon W; Park T; He J; Higuchi R; Son D; Lee SY; Kim J; Byun Y; Kim H; Kim SW; Wolfgang CL; Yamamoto M; Jang JY
    J Gastrointest Surg; 2020 Feb; 24(2):262-269. PubMed ID: 31823321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the prognostic value of the new AJCC 8th edition staging system for patients with pancreatic adenocarcinoma; a need to subclassify stage III?
    Song M; Yoon SB; Lee IS; Hong TH; Choi HJ; Choi MH; Lee MA; Jung ES; Choi MG
    Eur J Cancer; 2018 Nov; 104():62-69. PubMed ID: 30326370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of the 7 th and 8 th Editions of the American Joint Committee on Cancer Staging System in Patients with Intraductal Papillary Mucinous Neoplasm-Associated PDAC : A Multi-institutional Analysis.
    Margonis GA; Pulvirenti A; Morales-Oyarvide V; Buettner S; Andreatos N; Kamphues C; Beyer K; Wang J; Kreis ME; Cameron JL; Weiss MJ; Soares K; Fernández-Del Castillo C; Allen PJ; Wolfgang CL
    Ann Surg; 2023 Apr; 277(4):681-688. PubMed ID: 34793353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refining the American Joint Committee on Cancer Staging Scheme For Resectable Pancreatic Ductal Adenocarcinoma Using Recursive Partitioning Analysis.
    Jiang Y; Su Y; Chen Y; Li Z
    J Cancer; 2017; 8(14):2765-2773. PubMed ID: 28928865
    [No Abstract]   [Full Text] [Related]  

  • 35. Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer.
    Schouten TJ; Daamen LA; Dorland G; van Roessel SR; Groot VP; Besselink MG; Bonsing BA; Bosscha K; Brosens LAA; Busch OR; van Dam RM; Fariña Sarasqueta A; Festen S; Groot Koerkamp B; van der Harst E; de Hingh IHJT; Intven M; Kazemier G; de Meijer VE; Nieuwenhuijs VB; Raicu GM; Roos D; Schreinemakers JMJ; Stommel MWJ; van Velthuysen MF; Verdonk RC; Verheij J; Verkooijen HM; van Santvoort HC; Molenaar IQ;
    Ann Surg Oncol; 2022 Sep; 29(9):5988-5999. PubMed ID: 35469113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor location as an indicator of survival in T1 resectable pancreatic ductal adenocarcinoma: a propensity score-matched analysis.
    Meng Z; Cao M; Zhang Y; Liu Z; Wu S; Wu H
    BMC Gastroenterol; 2019 Apr; 19(1):59. PubMed ID: 31014264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reconsidering the American Joint Committee on Cancer Eighth Edition TNM Staging Manual Classifications for T2b and T3 NSCLC.
    Kumar A; Kumar S; Gilja S; Potter AL; Raman V; Muniappan A; Liou DZ; Jeffrey Yang CF
    J Thorac Oncol; 2021 Oct; 16(10):1672-1683. PubMed ID: 34242788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Eighth Edition of the American Joint Committee on Cancer Distant Metastases Stage Classification for Metastatic Pancreatic Neuroendocrine Tumors Might Be Feasible for Metastatic Pancreatic Ductal Adenocarcinomas.
    Wen J; Chen J; Liu D; Xu X; Fan M; Zhang Z
    Neuroendocrinology; 2020; 110(5):364-376. PubMed ID: 31357196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
    Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
    Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modifications.
    Zhu X; Chen D; Cao Y; Zhao X; Ju X; Shen Y; Cao F; Qing S; Fang F; Jia Z; Zhang H
    Cancer Biol Med; 2020 May; 17(2):492-500. PubMed ID: 32587784
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.